- Home
- INDP vs SILO Comparison
INDP vs SILO Comparison
Compare INDP & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- SILO
- Stock Information
- Founded
- INDP 2000
- SILO 2010
- Country
- INDP United States
- SILO United States
- Employees
- INDP N/A
- SILO N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- SILO Apparel
- Sector
- INDP Health Care
- SILO Consumer Discretionary
- Exchange
- INDP Nasdaq
- SILO Nasdaq
- Market Cap
- INDP 6.0M
- SILO 5.9M
- IPO Year
- INDP N/A
- SILO N/A
- Fundamental
- Price
- INDP $2.40
- SILO $0.68
- Analyst Decision
- INDP Strong Buy
- SILO
- Analyst Count
- INDP 2
- SILO 0
- Target Price
- INDP $238.00
- SILO N/A
- AVG Volume (30 Days)
- INDP 77.0K
- SILO 289.1K
- Earning Date
- INDP 08-13-2025
- SILO 08-13-2025
- Dividend Yield
- INDP N/A
- SILO N/A
- EPS Growth
- INDP N/A
- SILO N/A
- EPS
- INDP N/A
- SILO N/A
- Revenue
- INDP N/A
- SILO $72,102.00
- Revenue This Year
- INDP N/A
- SILO $1.86
- Revenue Next Year
- INDP N/A
- SILO N/A
- P/E Ratio
- INDP N/A
- SILO N/A
- Revenue Growth
- INDP N/A
- SILO N/A
- 52 Week Low
- INDP $2.47
- SILO $0.41
- 52 Week High
- INDP $58.24
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- INDP 18.11
- SILO 55.27
- Support Level
- INDP $6.26
- SILO $0.58
- Resistance Level
- INDP $6.65
- SILO $0.65
- Average True Range (ATR)
- INDP 0.69
- SILO 0.04
- MACD
- INDP -0.33
- SILO 0.00
- Stochastic Oscillator
- INDP 1.86
- SILO 81.19
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.